" /> Cyclophosphamide/Dexamethasone/Rituximab Regimen - CISMeF





Preferred Label : Cyclophosphamide/Dexamethasone/Rituximab Regimen;

NCIt synonyms : Dexamethasone/Rituximab/Cyclophosphamide; DRC; DRC Regimen; Dexamethasone/Rituximab/Cyclophosphamide Regimen; Cyclophosphamide/Dexamethasone/Rituximab; Cyclophosphamide-Dexamethasone-Rituximab; Cytoxan/Decadron/Rituxan; Oral Cyclophosphamide/Dexamethasone/Rituximab; Oral Cyclophosphamide/Dexamethasone Plus Rituximab;

NCIt related terms : DRC (SC rituximab) (rituximab-rixi); DRC (SC rituximab) (rituximab-rite); DRC (SC rituximab) (rituximab-pvvr); DRC (SC rituximab) (rituximab-blit); DRC (SC rituximab) (rituximab-abbs); DRC (SC rituximab) (rituximab-rixa); DRC (rituximab-rixi); DRC (rituximab-rite); DRC (rituximab-arrx); DRC (rituximab-blit); DRC (rituximab-pvvr); DRC (rituximab-rixa); DRC (rituximab-abbs); DRC (SC rituximab) (rituximab-arrx);

NCIt definition : A regimen consisting of cyclophosphamide, dexamethasone and rituximab that may be used in the treatment of Waldenstrom macroglobulinemia.;

NCI Metathesaurus CUI : CL969494;

Codes from synonyms : 38503; 128479; 128636; 128637; 128793; 128794; 128323; 127851; 127852; 128008; 128009; 128480; 128165; 128166; 128322;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
01/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.